| Jefferey Pham Dental Corp | |
|
7812 Warner Ave Huntington Beach CA 92647-4700 | |
| (714) 375-3222 | |
| (714) 375-3223 |
| Full Name | Jefferey Pham Dental Corp |
|---|---|
| Speciality | Clinic/Center |
| Location | 7812 Warner Ave, Huntington Beach, California |
| Authorized Official Name and Position | Jefferey Pham (CEO) |
| Authorized Official Contact | 7148230854 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Jefferey Pham Dental Corp 15701 Spar St Garden Grove CA 92843-5353 Ph: (714) 823-0854 | Jefferey Pham Dental Corp 7812 Warner Ave Huntington Beach CA 92647-4700 Ph: (714) 375-3222 |
| NPI Number | 1144748344 |
|---|---|
| Provider Enumeration Date | 09/07/2017 |
| Last Update Date | 09/07/2017 |
| Medicare PECOS PAC ID | 4284978784 |
|---|---|
| Medicare Enrollment ID | O20181211001887 |
News Archive
Children given an injectable medication to help prevent severe respiratory illness had a 17.6 percent higher likelihood of receiving the American Academy of Pediatrics (AAP) recommended doses when they were administered through a specialty pharmacy rather than a traditional pharmacy, according to a new study released today by pharmacy benefit manager Prime Therapeutics (Prime).
New research confirms that childhood onset temporal lobe epilepsy has a significant impact on brain aging. Study findings published in Epilepsia, a peer-reviewed journal of the International League Against Epilepsy (ILAE), show age-accelerated ventricular expansion outside the normal range in this patient population.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144748344 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | 63830 (California) | Primary |
| Provider Name | Jefferey Pham |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1033510771 PECOS PAC ID: 9638478381 Enrollment ID: I20190506000237 |
News Archive
Children given an injectable medication to help prevent severe respiratory illness had a 17.6 percent higher likelihood of receiving the American Academy of Pediatrics (AAP) recommended doses when they were administered through a specialty pharmacy rather than a traditional pharmacy, according to a new study released today by pharmacy benefit manager Prime Therapeutics (Prime).
New research confirms that childhood onset temporal lobe epilepsy has a significant impact on brain aging. Study findings published in Epilepsia, a peer-reviewed journal of the International League Against Epilepsy (ILAE), show age-accelerated ventricular expansion outside the normal range in this patient population.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
› Verified 4 days ago
News Archive
Children given an injectable medication to help prevent severe respiratory illness had a 17.6 percent higher likelihood of receiving the American Academy of Pediatrics (AAP) recommended doses when they were administered through a specialty pharmacy rather than a traditional pharmacy, according to a new study released today by pharmacy benefit manager Prime Therapeutics (Prime).
New research confirms that childhood onset temporal lobe epilepsy has a significant impact on brain aging. Study findings published in Epilepsia, a peer-reviewed journal of the International League Against Epilepsy (ILAE), show age-accelerated ventricular expansion outside the normal range in this patient population.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
› Verified 4 days ago
Jequinto Dental, Inc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 7801 Center Ave Ste 101, Huntington Beach, CA 92647 Phone: 210-568-9800 | |
Daniel Jaffe, D.d.s., Inc. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 305 Orange Ave Ste C, Huntington Beach, CA 92648 Phone: 714-374-1833 Fax: 714-374-0492 | |
Andrew Levin Dental Corporation Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 7891 Talbert Ave Ste 102, Huntington Beach, CA 92648 Phone: 714-842-4148 | |
Magic Fox Orthodontics Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 17041 Beach Blvd Ste 101, Huntington Beach, CA 92647 Phone: 949-409-8491 | |
Dental Office Of Joel Henriod Dds Inc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 17762 Beach Blvd Ste 210, Huntington Beach, CA 92647 Phone: 714-898-2517 | |
Rudolph S Gamarnik & Scott D Christensen Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 6968 Warner Ave, Huntington Beach, CA 92647 Phone: 714-842-5593 | |
Shah Patel Dental Partnership Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4911 Warner Ave Ste 202, Huntington Beach, CA 92649 Phone: 714-846-4414 |